Navarria, P., Pessina, F., Tomatis, S., Simonelli, M., Santoro, A., Ascolese, A., . . . Scorsetti, M. (2017). P09.36 A new therapeutic strategy for newly diagnosed glioblastoma patients: Hypofractionated stereotactic radiation therapy (HSRT) delivered in 15 fractions respect to standard fractionation in 30 fractions, with concomitant temozolomide chemotherapy - A phase II study. Neuro Oncol.
Citación estilo ChicagoNavarria, P., et al. "P09.36 A New Therapeutic Strategy for Newly Diagnosed Glioblastoma Patients: Hypofractionated Stereotactic Radiation Therapy (HSRT) Delivered in 15 Fractions Respect to Standard Fractionation in 30 Fractions, With Concomitant Temozolomide Chemotherapy - A phase II Study." Neuro Oncol 2017.
Cita MLANavarria, P., et al. "P09.36 A New Therapeutic Strategy for Newly Diagnosed Glioblastoma Patients: Hypofractionated Stereotactic Radiation Therapy (HSRT) Delivered in 15 Fractions Respect to Standard Fractionation in 30 Fractions, With Concomitant Temozolomide Chemotherapy - A phase II Study." Neuro Oncol 2017.